Skip to main content Accessibility help
×
Hostname: page-component-8448b6f56d-qsmjn Total loading time: 0 Render date: 2024-04-20T10:08:27.485Z Has data issue: false hasContentIssue false

1 - Introduction

Published online by Cambridge University Press:  02 December 2009

Michael P. Barnes
Affiliation:
Walkergate Park, International Centre for Neurorehabilitation and Neuropsychiatry, Newcastle upon Tyne, UK
Anthony B. Ward
Affiliation:
North Staffordshire Rehabilitation Centre, Stoke-on-Trent, UK
Anthony B. Ward
Affiliation:
University Hospital of North Staffordshire
Michael P. Barnes
Affiliation:
Hunters Moor Regional Neurological Rehabilitation Centre
Get access

Summary

Introduction

This book has been written to highlight the remarkable progress in the application of botulinum toxin in medical practice. It is used across many specialties and has an increasing indication across a whole spectrum of diseases. As a result, its commercial sales have grown exponentially and its use in cosmesis has made ‘BOTOX®’ a household name. This is extraordinary after such a short time in this field and some other products have even gone so far as to add an ‘-ox’ on the end of their brand name to attempt to capture some of the kudos (and market) of botulinum toxin. This is of course very different from when the drug was first marketed and when it was regarded as a highly dangerous product. The indications for botulinum toxin treatment are listed in Chapter 5. In many, there is still little or no evidence that it works, but in others, there is good evidence of its therapeutic benefit.

History of BoNT

Botulinum toxin was first identified as a poison in the nineteenth century. The toxin is a protein, which is produced by the Gram negative Clostridium botulinum bacterium. It is found in a variety of foods, but is most common in meat products. The name botulus means sausage and hence its terminology from its appearance in meat products. The features of botulism have been known since around the time of Christ and it was certainly described in the Middle Ages.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Kerner, J. (1817). Vergiftungdurch verdorbene Würste. Ubinger Blätter Naturwissenschaften Arzneykunde, 3, 1–25.Google Scholar
Kerner, J. (1820). Neue Beobachtungen über die in Würtenburg so haufig vorfallenden todlichen Vergiftungen durch den Genuss geraucherter Würste. Tübingen: Osiander.
Kerner, J. (1822). Das Fettgift oder die Fettsäure und irhe Wirkungen afu der theirischen Organisnmus, ein Beytragzur Untersuchung des in verdobenen Würsten giftig wirkenden Stoffes. Stuttgart, Tübingen: Cotta.
Ermengem, E. P. (1897). Uber einen neuen aneroben Bacillus und sein Beziehung zum Botulismus. Z. Hyg. Infektionskrankh, 26, 1–56.Google Scholar
Schantz, E. J. (1994). Historical perspective. In J. Jankovic and M. Hallett, eds., Therapy with Botulinum Toxin. New York: Marcel Dekker Inc, pp. xxiii–xxvi.Google Scholar
Burgen, A., Dickens, F. and Zatman, L. J. (1949). The action of botulinum toxin on the neuromuscular junction. Journal of Physiology, 109, 10–24.CrossRefGoogle Scholar
Drachman, D. (1964). Atrophy of skeletal muscles in chick embryos treated with botulinum toxin. Science, 145, 719–21.CrossRefGoogle ScholarPubMed
Drachman, D. B. and Houk, J. (1969). The effect of botulinum toxin on speed of muscle contraction. American Journal of Physiology, 216, 1435–55.Google ScholarPubMed
Scott, A. B., Rosenbaum, A. and Collins, C. C. (1973). Pharmacological weakening of extra-ocular muscles. Invest. Ophthalmol. Vis. Sci., 12, 924–7.Google Scholar
Schiavo, G., Poulain, B., Rosetto, O., et al. (1992). Tetanus toxin is a zinc protein and its inhibition of neurotransmitter release and protease activity depend on zinc. EMBO J., 11, 3577–83.Google ScholarPubMed
Schiavo, G., Benefenati, E., Poulain, B., et al. (1992). Tetanus and botulinum B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature, 359, 832–4.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Introduction
    • By Michael P. Barnes, Walkergate Park, International Centre for Neurorehabilitation and Neuropsychiatry, Newcastle upon Tyne, UK, Anthony B. Ward, North Staffordshire Rehabilitation Centre, Stoke-on-Trent, UK
  • Edited by Anthony B. Ward, Michael P. Barnes
  • Book: Clinical Uses of Botulinum Toxins
  • Online publication: 02 December 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511544842.001
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Introduction
    • By Michael P. Barnes, Walkergate Park, International Centre for Neurorehabilitation and Neuropsychiatry, Newcastle upon Tyne, UK, Anthony B. Ward, North Staffordshire Rehabilitation Centre, Stoke-on-Trent, UK
  • Edited by Anthony B. Ward, Michael P. Barnes
  • Book: Clinical Uses of Botulinum Toxins
  • Online publication: 02 December 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511544842.001
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Introduction
    • By Michael P. Barnes, Walkergate Park, International Centre for Neurorehabilitation and Neuropsychiatry, Newcastle upon Tyne, UK, Anthony B. Ward, North Staffordshire Rehabilitation Centre, Stoke-on-Trent, UK
  • Edited by Anthony B. Ward, Michael P. Barnes
  • Book: Clinical Uses of Botulinum Toxins
  • Online publication: 02 December 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511544842.001
Available formats
×